Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

413.95INR
20 Sep 2019
Change (% chg)

Rs3.05 (+0.74%)
Prev Close
Rs410.90
Open
Rs414.00
Day's High
Rs420.60
Day's Low
Rs408.10
Volume
443,867
Avg. Vol
463,075
52-wk High
Rs655.00
52-wk Low
Rs350.40

Summary

Name Age Since Current Position

Israel Makov

79 2012 Non-Executive Chairman of the Board

C. Muralidharan

2017 Chief Financial Officer

Sunil Ajmera

2011 Compliance Officer, Company Secretary

Dilip Shanghvi

63 2012 Managing Director, Executive Director

Sailesh Desai

63 1999 Whole-time Director

Kalyanasundaram Subramanian

64 2017 Whole Time Director

Gautam Doshi

65 2018 Additional Director

Sudhir Valia

61 2019 Non-Executive and Non-Independent Director

Vivek Sehgal

61 2017 Additional Independent Director

S. Mohanchand Dadha

1997 Non-Executive Independent Director

Ashwin Dani

76 Non-Executive Independent Director

Keki Mistry

63 2002 Non-Executive Independent Director

Rekha Sethi

2015 Non-Executive Independent Director

Nimish Desai

IR Officer

Biographies

Name Description

Israel Makov

Mr. Israel Makov is Non-Executive Chairman of the Board of Sun Pharmaceutical Industries Limited., effective May 29, 2012. Mr. Israel Makov is a Non-executive Chairman of the Company since May 29, 2012. He is also the former President and CEO of Teva Pharmaceutical Industries Ltd. He joined Teva in 1995 and led the company’s global expansion, managing over 12 acquisitions, two of which were the largest M&A deals in the Israeli history at the time. Under Mr. Makov’s leadership, Teva became the undisputed global leader in the generic pharmaceutical industry and a global leader in the treatment of Multiple sclerosis. Mr Israel Makov is Chairman of BioLight – an emerging global ophthalmic company focused on the discovery, development and commercialization of products for ophthalmic conditions and Chairman of Micromedic Technologies Ltd. - a cluster of companies engaged in cancer diagnostics. Mr Makov is the former Chairman of Given Imaging - the developer and world’s leading provider of capsule endoscopy and Netafim - the pioneer and global leader in smart irrigation solutions. Mr. Israel Makov holds a B.Sc. in Agriculture and M. Sc in Economics from the Hebrew University, Jerusalem.

C. Muralidharan

Sunil Ajmera

Dilip Shanghvi

Mr. Dilip Shantilal Shanghvi is Managing Director, Executive Director of Sun Pharmaceutical Industries Limited. Mr. Dilip S. Shanghvi is a graduate in commerce from the University of Calcutta. He is the Managing Director of the Company and Chairman & Managing Director of Sun Pharma Advanced Research Company Ltd. He is the founding partner of Sun Pharmaceutical Industries, a firm which was later converted into Sun Pharmaceutical Industries Limited (SPIL) in 1993. Under his leadership, SPIL has recorded an all-round growth in business. He has extensive experience in the pharmaceutical industry. As the promoter of SPIL, he has been actively involved in international pharmaceutical markets, business strategy, business development and research and development functions in the Company.

Sailesh Desai

Mr. Sailesh T. Desai is Whole-time Director of Sun Pharmaceutical Industries Limited. Mr. Sailesh T. Desai is a science graduate from Kolkata University and is a successful entrepreneur with more than three decades of wide industrial experience including more than two decades in the pharmaceutical industry

Kalyanasundaram Subramanian

Mr. Kalyanasundaram Subramanian is Whole Time Director of the Company. Mr. Kal joined Sun Pharmaceutical Industries Limited (SPIL) in January 2010 after 22 years with GSK in various parts of the world. Mr. Kal is a Chemistry graduate and a Chartered Accountant from India with 37 years of experience of which some 30 years in the pharmaceutical industry. Mr. Kal’s career in Pharma industry began when he joined Burroughs Wellcome, in New Zealand as Commercial Advisor in 1988. His long and varied career with Burroughs Wellcome in New Zealand which was acquired by Glaxo to become GlaxoWellcome and finally GlaxoSmithKline, includes assignments as Vice President, head of Classic Brands business of Emerging Markets; Area Director South Asia & Managing Director, GSK India; Managing Director – GlaxoWellcome, Singapore (Singapore, Indochina & Myanmar). Commercial Director - Burroughs Wellcome, New Zealand. In 2010, Mr. Kal Joined SPIL as the Chief Executive Officer to manage India and Emerging Markets (EM) and was a board member of the Company. Mr. Kalyansundaram Subramanian spearheaded opening of SPIL operations in few important markets such as Japan, MENA. In 2012, Mr. Kal moved to USA to assume responsibility for Taro operations in North America. In Jan 2017, Mr. Kal moved back to India to manage India and EM regions of SPIL. He is CEO of Sun Pharma Laboratories Limited

Gautam Doshi

Shri. Gautam Bhailal Doshi is Additional Director of the Company. Mr. Gautam Doshi, a Chartered Accountant and Masters in Commerce, has been in professional practice for over 40 years. He advises various industrial groups and families and also serves as director on boards of public listed and unlisted companies. Mr. Doshi has more than 40 years of experience in wide range of areas covering Mergers and Acquisitions, Direct, Indirect and International Taxation, Transfer Pricing, Accounting and Corporate and Commercial Laws. He has been actively involved in conceptualizing and implementing a number of mergers and restructuring transactions both domestic and cross border, involving many of the top 20 listed companies on BSE as also those forming part of FTSE 100. A prolific speaker, Mr Doshi has addressed several seminars and conferences within and outside of India and courses organized by the Institute of Chartered Accountants of India, International Fiscal Association, Other professional bodies and Chambers of Commerce. He has served on the Councils of Western Region as also All India level of the Institute of Chartered Accountants of India which has the task of development and regulation of profession of accountancy in India. During his tenure on the Council, he served on several committees and contributed significantly to the work of Board of Studies which is responsible for education and system of training of students. He also served as Chairman of Committees on direct and indirect taxation.

Sudhir Valia

Mr. Sudhir V. Valia is Non-Executive and Non-Independent Director of Sun Pharmaceutical Industries Limited. Mr. Sudhir V. Valia holds a Bachelor’s degree in Commerce from University of Mumbai and is also a qualified Chartered Accountant with more than three decades of taxation and finance experience. He has been the Director of Sun Pharmaceutical Industries Limited since 1994 and is also on the Board of Taro Pharmaceutical Industries Ltd. Mr. Valia has won several awards including CNBC TV 18’s CFO of the Year in the Pharmaceutical and Healthcare Sectors for two consecutive years - 2011 and 2012, as well as in the year 2009. He is actively involved in the field of social activities and he was awarded the Adivasi Sevak Puraskar (2008 -2009) by the Government of Maharashtra for his contribution towards the welfare of tribals, particularly in the field of education in his capacity as visionary and Director of Shantilal Shanghvi Foundation. He is also a Director of Krishna Vrundavan Pratishthan.

Vivek Sehgal

Mr. Vivek Chaand Sehgal is Additional Independent Director of the company. Mr. Vivek Chaand Sehgal is the Chairman of Samvardhana Motherson Group (SMG). In 1977 he entered the field of manufacturing with a cable and wire manufacturing unit. SMG is present in 37 countries with over 230 facilities across the globe. Motherson Sumi Systems Limited (MSSL), the flagship company of SMG, is now one of the largest auto ancillary companies in India. The Group has a diversified product range covering wiring harnesses, rear view mirrors, integrated plastic modules, lighting systems and a wide range of modules and components. SMG today is one of the leading suppliers of rearview mirrors globally & the leading supplier of polymer modules in Europe along with market leadership positions in most of the other product verticals in India. Under the leadership of Mr. Sehgal, SMG has evolved as a leading full system solutions provider to the global automotive industry He is a visionary who has the ability of sighting opportunities for the benefit of the Group whether it be in the form of joint ventures or acquisitions. Among the many accolades he has received, Mr. Sehgal was adjudged Man of the Year 2010 by Auto Car Professional Magazine. He received Ernst & Young Entrepreneur of the Year Award for manufacturing in 2012. He has been adjudged the Best CEO, 2013 for Auto Ancillaries by Business Today Magazine in India. He was adjudged as the “CEO of the Year 2015” by Business Standard. He also received the Best CEO award in 2016 in all Asia Executive Team Rankings for autos and auto parts sector by Institutional Investor Magazine. Recently Mr. Sehgal has been declared EY Entrepreneur of the Year 2016.

S. Mohanchand Dadha

Mr. S. Mohanchand Dadha is Non-Executive Independent Director of Sun Pharmaceutical Industries Limited. He is an entrepreneur with more than five decades of wide experience in Pharma Industry and has competent knowledge and experience in financial and accounting areas, Mr. Dadha was Managing Director and Promoter of erstwhile Tamilnadu Dadha Pharmaceuticals Ltd. He is also trustee of many Charitable Trusts. He was the Member of Tamilnadu Government constituted Drug Committees, namely The Drug Advisory Committee and the Committee for the development of Drug Industries in Tamilnadu. Presently, he is also a Director in the following Companies are Sun Pharma Advanced Research Company Ltd., Wardex Pharmaceuticals Ltd., Dadha Pharma Pvt. Ltd., and Kerala Chemists and Distributors Alliance Ltd. He served as the Chairman of the Audit Committee and Remuneration Committee of Sun Pharma Advanced Research Company Ltd.

Ashwin Dani

Mr. Ashwin S. Dani is Non-Executive Independent Director of Sun Pharmaceutical Industries Limited. He is a science graduate from the Institute of Science, University of Mumbai and U.D.C.T., University of Mumbai. He also holds a Masters Degree in polymer science from University of Akron, Ohio, USA and Diploma in colour science from Rensellaer Polytechnic, Troy, New York. He is Vice Chairman and Managing Director of Asian Paints (India) Limited. He also holds a number of directorships and has been nominated by the government as a Trustee on the Central Board of Trustees of the Employees Provident Fund. He is also a member of the executive committee of the Federation of Indian Chambers of Commerce and industry.

Keki Mistry

Shri. Keki Minoo Mistry, CPA, is Non-Executive Independent Director of Sun Pharmaceutical Industries Limited. He is a Fellow Member of the Institute of Chartered Accountants of India and a Member of the Michigan Association of Certified Public Accountants, USA. He is the Managing Director of the Housing Development Finance Corporation Limited. He has worked as a consultant to the Commonwealth Development Corporation in various emerging markets as well as to the Asian Development Bank. He holds a number of directorships and is a member of the management committee of the Bombay Chamber of Commerce & Industry.

Rekha Sethi

Ms. Rekha Sethi is Non-Executive Independent Director of the company.

Nimish Desai

Basic Compensation

Name Fiscal Year Total

Israel Makov

900,000

C. Muralidharan

22,830,000

Sunil Ajmera

13,410,000

Dilip Shanghvi

30,087,300

Sailesh Desai

12,283,100

Kalyanasundaram Subramanian

--

Gautam Doshi

--

Sudhir Valia

29,943,700

Vivek Sehgal

300,000

S. Mohanchand Dadha

1,600,000

Ashwin Dani

700,000

Keki Mistry

800,000

Rekha Sethi

1,300,000

Nimish Desai

--
As Of  31 Mar 2018